Dr. Alex Gorbonos, MD

Dr. Gorbonos practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Gorbonos' NPI, 1538341060, was assigned on November 27, 2007. Dr. Gorbonos graduated from Albert Einstein College of Medicine of Yeshiva University in 2003. Dr. Gorbonos holds Illinois license 036-116265.

Dr. Gorbonos' primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Gorbonos' primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Gorbonos is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dmand AI also links Dr. Gorbonos to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Gorbonos' employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorbonos practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gorbonos' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gorbonos is licensed in Illinois.

CMS data shows 718 Medicare services from Dr. Gorbonos across 12 procedure codes in 2024, for 381 Medicare patients. Medicare paid $58,055 for them.

CMS counts 381 Medicare patients who saw Dr. Gorbonos in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gorbonos' median patient age at 73, with 18% women.

In 2024, Dr. Gorbonos wrote 1,148 Medicare Part D claims for 242 patients. 89% of them were for generic drugs. CMS names the drug for 1,043 of them, across 10 drugs with 11 or more claims each, at $160,219 in total drug cost. In 2023, CMS named 786 claims across 8 drugs.

Dr. Gorbonos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gorbonos as offering telehealth. CMS counts 17 procedures of prostate resection by Dr. Gorbonos, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Gorbonos, published from 2007 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Prostate. Dr. Gorbonos has published most often in Urol Oncol. Dr. Gorbonos' most frequent co-authors are Marcus Lee Quek, MD, Robert Charles Flanigan, MD and Goran Rac, MD.

Dmand AI links Dr. Gorbonos to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 51 general payments to Dr. Gorbonos from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 77% of the total. Boston Scientific Corporation paid the most, $2,562.

Dr. Gorbonos graduated from Albert Einstein College of Medicine of Yeshiva University in 2003.